Summary
Background Endophthalmitis is one of the most important adverse events after cataract surgery as it can lead to total vision loss. The aim of this study was to describe the occurrence of endophthalmitis after phacoemulsification with intraocular lens implantation among patients assisted during a joint effort in Porto Velho, Rondônia, Brazil.
Method This is a retrospective cohort study, carried out from a bank with 649 medical records of patients who underwent surgery. Descriptive analysis and multiple analysis using Robust Poisson Regression were performed to estimate relative risks (RR) and 95% confidence intervals (95%CI). A statistical analysis was performed using the statistical program Stata® version 16.0 (College Station, Texas, USA).
Results The incidence of postoperative endophthalmitis confirmed by culture was 10.88%, the highest ever recorded in the world. A higher risk for endophthalmitis was found, in probable cases, among males (RR: 1.88; 95%CI:1.03; 3.44) and brown and yellow skin color (RR: 2.78; 95 %CI %: 1.17; 6.60). For confirmed and probable cases, bilateral surgery and specific lens model were also risk factors. The predominant etiological agents were gram-negative and the main clinical manifestation was corneal edema. The average number of days to start treatment was eight days and 27.12% used antibiotics.
Conclusion Specific protocols are needed for cataract surgeries that encompass hiring, performing and monitoring these services to ensure good practices and patient safety.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is part of the matrix project entitled "Good Practices in Patient Care, Infection Control and Processing of Health Products in the State of Rondonia", authorized by the Ethics and Research Committee of the Federal University of Rondonia, Brazil, CAE 20070719.5.0000.5300.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Endereço atual: #umaDepartamento de Enfermagem, Universidade Federal de Rondônia, Campus Ribeiro Filho, km 9,5, sentido Acre, CEP 76801-059. Porto Velho, Rondônia, RO, Brasil.
Conceptualization: PPSP, AACS, RMFA, DOP
Data Curation: PPSP, AACS, RMFA, DOP, MMBMA, VAS, MSA, ASB, SFR, EBS
Formal Analysis: PPSP, AACS, RMFA, DOP
Investigation: RMFA, DOP, MMBMA, VAS, MSA, ASB, SFR, EBS
Methodology: PPSP, AACS, RMFA, DOP Project Administration: PPSP
Supervision: PPSP, AACS, RMFA, DOP, MMBMA
Writing – Original Draft Preparation: PPSP, AACS, RMFA, DOP, MMBMA, VAS, MSA, ASB, SFR, EBS
Writing – Review & Editing: PPSP, AACS, RMFA, DOP, MMBMA, VAS, MSA, ASB, SFR, EBS
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
